山本　雅之 Univ. Tsukuba Nrf2(+/-)::AhR(+/-) compound mouse Nrf2(+/-)::AhR(+/-) compound mouse Masayuki YAMAMOTO STOCK Ahr<tm1Yfk> Nfe2l2<tm1Mym> STOCK Ahr<tm1Yfk> Nfe2l2<tm1Mym> 国立大学法人筑波大学 RBRC01236 C (3-6 months) The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Noda S.et al. (2003) BIochem Biophys Res Commun. 303:105-111.In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE during the first 2 years after deposition by the DEPOSITOR to the RIKEN BRC. The RECIPIENT should contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. C（3〜6か月） Simian virus 40 Large T antigen nuclear localization signal (NLS), E. coli lacZ, herpes simplex virus thymidine kinase promoter (HSV tk promoter), E. coli neo, mouse Nrf2 genomic DNA, mouse Ahr genomic DNA, SV40 T antigen intron and polyadenylation signal Cell Biology Research 129SV・C57BL6J・ICR雑種 Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="http://www.dmbc.med.tohoku.ac.jp/official/index.html" target="_blank">Lab HP (Japanese)</A> AhR(-/-)雌は生殖能が低い 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Noda S.et al. (2003) BIochem Biophys Res Commun. 303:105-111.<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>寄託後2年間は共著を必要とする共同研究とする。当該リソースを使用した研究結果に基づき特許等の申請を行う場合は、寄託者と別途協議を行う。 true